NDC 70518-2399

ADMELOG

Insulin Lispro

ADMELOG is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Insulin Lispro.

Product ID70518-2399_967b9b62-abe6-f0ab-e053-2995a90a7fd7
NDC70518-2399
Product TypeHuman Prescription Drug
Proprietary NameADMELOG
Generic NameInsulin Lispro
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2019-10-30
Marketing CategoryNDA / NDA
Application NumberNDA209196
Labeler NameREMEDYREPACK INC.
Substance NameINSULIN LISPRO
Active Ingredient Strength100 U/mL
Pharm ClassesInsulin [Chemical/Ingredient],Insulin Analog [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 70518-2399-0

1 VIAL in 1 CARTON (70518-2399-0) > 3 mL in 1 VIAL
Marketing Start Date2019-10-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-2399-0 [70518239900]

ADMELOG INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA209196
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-10-30

Drug Details

Active Ingredients

IngredientStrength
INSULIN LISPRO100 U/mL

Pharmacological Class

  • Insulin [Chemical/Ingredient]
  • Insulin Analog [EPC]
  • Insulin [Chemical/Ingredient]
  • Insulin Analog [EPC]

NDC Crossover Matching brand name "ADMELOG" or generic name "Insulin Lispro"

NDCBrand NameGeneric Name
0024-5924ADMELOGADMELOG
0024-5926ADMELOGADMELOG
0024-5925ADMELOGADMELOG
70518-2399ADMELOGADMELOG
0002-7510HumalogInsulin lispro
0002-7511HumalogInsulin lispro
0002-7512HumalogInsulin lispro
0002-7516HumalogInsulin lispro
0002-7712HumalogInsulin lispro
0002-7714HumalogInsulin lispro

Trademark Results [ADMELOG]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ADMELOG
ADMELOG
87682668 5475626 Live/Registered
Sanofi
2017-11-13
ADMELOG
ADMELOG
86787842 5080517 Live/Registered
Sanofi
2015-10-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.